
LeMaitre Vascular LMAT
$ 83.95
-0.46%
Quarterly report 2025-Q3
added 11-07-2025
LeMaitre Vascular Depreciation & Amortization 2011-2025 | LMAT
Annual Depreciation & Amortization LeMaitre Vascular
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.67 M | 9.52 M | 9.43 M | 11.1 M | 8.4 M | 5.42 M | 4.32 M | 4.06 M | 3.59 M | 3.39 M | 3.33 M | 2.79 M | 2.23 M | 2.04 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.1 M | 2.04 M | 5.66 M |
Quarterly Depreciation & Amortization LeMaitre Vascular
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.44 M | 1.44 M | 2.55 M | 1.46 M | 1.47 M | 2.38 M | 1.54 M | 1.51 M | 2.35 M | - | 1.54 M | 1.6 M | 2.37 M | - | 8.19 M | 1.56 M | 2.62 M | - | 5.86 M | 3.18 M | 1.54 M | - | 3.98 M | 2.63 M | 1.28 M | - | 3.11 M | 2.1 M | 1.04 M | - | 2.97 M | 1.96 M | 979 K | - | 2.66 M | 1.81 M | 881 K | - | 2.5 M | 1.67 M | 832 K | - | 2.42 M | 1.62 M | 831 K | - | 1.97 M | 1.25 M | 610 K | - | 1.63 M | 1.1 M | 548 K | - | 1.47 M | 950 K | 461 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.19 M | 461 K | 2 M |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
997 M | $ 19.32 | 1.05 % | $ 9.85 B | ||
|
Becton, Dickinson and Company
BDX
|
2.46 B | $ 196.18 | -0.01 % | $ 56.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
1.61 M | $ 5.47 | -0.01 % | $ 110 M | ||
|
Harvard Bioscience
HBIO
|
1.47 M | $ 0.71 | -1.78 % | $ 30.1 M | ||
|
Repro Med Systems
KRMD
|
870 K | $ 6.25 | -3.55 % | $ 285 M | ||
|
iRhythm Technologies
IRTC
|
20.7 M | $ 177.0 | 0.68 % | $ 5.52 B | ||
|
ICU Medical
ICUI
|
220 M | $ 148.17 | 0.81 % | $ 3.61 B | ||
|
AtriCure
ATRC
|
11.2 M | $ 40.7 | 0.37 % | $ 1.91 B | ||
|
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
962 K | $ 4.93 | 1.54 % | $ 27.2 K | ||
|
Isoray
ISR
|
2.31 M | - | 0.03 % | $ 108 M | ||
|
AngioDynamics
ANGO
|
25.8 M | $ 13.12 | -0.3 % | $ 536 M | ||
|
Merit Medical Systems
MMSI
|
103 M | $ 87.36 | -0.03 % | $ 5.09 B | ||
|
The Cooper Companies
COO
|
377 M | $ 82.55 | -0.03 % | $ 16.4 B | ||
|
Glaukos Corporation
GKOS
|
33.7 M | $ 116.08 | -0.56 % | $ 5.62 B | ||
|
Haemonetics Corporation
HAE
|
116 M | $ 80.39 | 0.36 % | $ 4.05 B | ||
|
InfuSystem Holdings
INFU
|
13.4 M | $ 8.93 | -1.71 % | $ 184 M | ||
|
Masimo Corporation
MASI
|
103 M | $ 132.7 | -0.44 % | $ 7.07 B | ||
|
OraSure Technologies
OSUR
|
10.9 M | $ 2.43 | - | $ 181 M | ||
|
Intuitive Surgical
ISRG
|
439 M | $ 578.08 | 0.16 % | $ 205 B | ||
|
Microbot Medical
MBOT
|
106 K | $ 2.16 | -0.88 % | $ 22 M | ||
|
Milestone Scientific
MLSS
|
37.4 K | $ 0.29 | -1.41 % | $ 23.1 M | ||
|
Nephros
NEPH
|
214 K | $ 4.98 | -4.78 % | $ 51.7 M | ||
|
STERIS plc
STE
|
476 M | $ 255.64 | 0.02 % | $ 25.2 B | ||
|
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
123 M | $ 21.99 | -0.05 % | $ 3.79 B | ||
|
Predictive Oncology
POAI
|
162 K | - | - | $ 32.4 M | ||
|
Pro-Dex
PDEX
|
1.24 M | $ 39.33 | -2.65 % | $ 129 M | ||
|
Utah Medical Products
UTMD
|
623 K | $ 56.66 | 0.66 % | $ 206 M | ||
|
Pulse Biosciences
PLSE
|
542 K | $ 14.45 | -2.76 % | $ 694 M | ||
|
ResMed
RMD
|
160 M | $ 245.14 | 0.3 % | $ 35.8 B | ||
|
DENTSPLY SIRONA
XRAY
|
349 M | $ 11.47 | 3.66 % | $ 2.33 B | ||
|
Repligen Corporation
RGEN
|
68.6 M | $ 165.37 | -0.18 % | $ 9.21 M | ||
|
BioLife Solutions
BLFS
|
5.16 M | $ 24.95 | -1.81 % | $ 1.15 B | ||
|
Stereotaxis
STXS
|
595 K | $ 2.46 | 1.23 % | $ 199 M | ||
|
STAAR Surgical Company
STAA
|
6.89 M | $ 23.37 | -1.1 % | $ 1.15 B | ||
|
Retractable Technologies
RVP
|
7.57 M | $ 0.82 | -0.51 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
275 M | $ 122.75 | 0.7 % | $ 5.75 B | ||
|
West Pharmaceutical Services
WST
|
155 M | $ 274.28 | -0.95 % | $ 20 B |